Nurse Practitioner, Psychiatric/Mental Health · Mesa, AZ
NPI
1841346186
Since 2007
Specialty
Nurse Practitioner, Psychiatric/Mental Health
Code 363LP0808X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
2135 E University Dr Ste 116
Mesa, AZ, 85213
Phone (480) 325-0313
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$892K
1,984 prescriptions
Company payments, 2025
$2,975
From 20 companies
Medicare prescription drug claims, 2024
In 2024, the drug Gail S Ziv prescribed most often to Medicare patients was Alprazolam, with 171 prescriptions and refills. In total Gail S Ziv wrote 1,984 Medicare prescriptions that cost $892K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-11-01.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Alprazolam Generic | 171 | 175 | 21 | $645 |
| Alprazolam Er Alprazolam | 125 | 125 | 14 | $4,522 |
| Quetiapine Fumarate Generic | 105 | 165 | 16 | $2,562 |
| Aripiprazole Generic | 91 | 229 | 23 | $3,392 |
| Lamotrigine Generic | 89 | 190 | 17 | $1,413 |
| Bupropion Xl Bupropion Hcl | 81 | 211 | 20 | $4,035 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 81 | 195 | 14 | $3,828 |
| Vraylar Cariprazine Hcl | 74 | 80 | Under 11 | $115K |
| Propranolol Hcl Generic | 59 | 103 | Under 11 | $1,313 |
| Zolpidem Tartrate Generic | 57 | 83 | Under 11 | $506 |
| Duloxetine Hcl Generic | 56 | 132 | 12 | $1,335 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 55 | 55 | Under 11 | $1,990 |
| Temazepam Generic | 43 | 55 | Under 11 | $391 |
| Escitalopram Oxalate Generic | 41 | 117 | 13 | $723 |
| Rexulti Brexpiprazole | 38 | 48 | Under 11 | $72K |
Brand drugs: 340 claims; generic drugs: 1,644 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gail S Ziv $2,975 ($2,975 in general payments such as food, travel and fees) from 20 companies. The largest payer was Abbvie Inc. with $476.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 28 | $476 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 29 | $411 |
| Teva Pharmaceuticals USA, Inc. TEVA | 13 | $378 |
| Tris Pharma Inc | 19 | $377 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 23 | $329 |
| Corium, LLC | 19 | $242 |
| Lundbeck LLC | 9 | $195 |
| Axsome Therapeutics, Inc. AXSM | 5 | $111 |
| Neurocrine BioSciences, Inc. NBIX | 4 | $86.72 |
| Almatica Pharma LLC | 3 | $69.04 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.